0001593968-20-001510.txt : 20200624
0001593968-20-001510.hdr.sgml : 20200624
20200624161957
ACCESSION NUMBER: 0001593968-20-001510
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200623
FILED AS OF DATE: 20200624
DATE AS OF CHANGE: 20200624
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Halpin Michael
CENTRAL INDEX KEY: 0001778858
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35280
FILM NUMBER: 20985728
MAIL ADDRESS:
STREET 1: C/O VERICEL CORPORATION
STREET 2: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vericel Corp
CENTRAL INDEX KEY: 0000887359
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943096597
STATE OF INCORPORATION: MI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7349305555
MAIL ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC
DATE OF NAME CHANGE: 19960428
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2020-06-23
0000887359
Vericel Corp
VCEL
0001778858
Halpin Michael
C/O VERICEL CORPORATION
64 SIDNEY STREET
CAMBRIDGE
MA
02139
false
true
false
false
Chief Operating Officer
Common Stock
2020-06-23
4
M
false
14751
7.2
A
16373
D
Common Stock
2020-06-23
4
S
false
14751
15.01
D
1622
D
Stock Option (right to buy)
7.20
2020-06-23
4
M
false
14751
0
D
2028-02-07
Common Stock
14751
20579
D
The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2020.
These options, representing the right to purchase a total of 40,330 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted.
/s/ Michael Halpin
2020-06-24